| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pollen | 17 | 2017 | 39 | 3.410 |
Why?
|
| Asthma | 23 | 2022 | 922 | 3.170 |
Why?
|
| Allergens | 15 | 2018 | 344 | 2.310 |
Why?
|
| Neutrophils | 8 | 2017 | 371 | 1.900 |
Why?
|
| Respiratory Hypersensitivity | 8 | 2016 | 57 | 1.840 |
Why?
|
| DNA Damage | 10 | 2022 | 511 | 1.610 |
Why?
|
| Immunity, Innate | 8 | 2018 | 406 | 1.560 |
Why?
|
| Neutrophil Infiltration | 5 | 2017 | 63 | 1.500 |
Why?
|
| DNA Glycosylases | 13 | 2023 | 26 | 1.450 |
Why?
|
| Antigens, Plant | 7 | 2017 | 35 | 1.360 |
Why?
|
| Lung | 15 | 2021 | 1535 | 1.350 |
Why?
|
| Oxidative Stress | 17 | 2022 | 791 | 1.330 |
Why?
|
| DNA Repair | 10 | 2022 | 571 | 1.150 |
Why?
|
| Rhinitis, Allergic, Seasonal | 4 | 2017 | 17 | 1.110 |
Why?
|
| Respiratory Mucosa | 9 | 2018 | 93 | 1.060 |
Why?
|
| Dander | 3 | 2018 | 4 | 1.030 |
Why?
|
| Th2 Cells | 6 | 2017 | 188 | 1.020 |
Why?
|
| Ambrosia | 9 | 2017 | 14 | 1.020 |
Why?
|
| Hypersensitivity | 6 | 2018 | 227 | 0.970 |
Why?
|
| Reactive Oxygen Species | 18 | 2022 | 521 | 0.970 |
Why?
|
| Eosinophils | 6 | 2019 | 122 | 0.950 |
Why?
|
| Receptors, Interleukin-8B | 4 | 2018 | 15 | 0.930 |
Why?
|
| Bronchoalveolar Lavage Fluid | 9 | 2017 | 152 | 0.830 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2017 | 142 | 0.820 |
Why?
|
| Plant Extracts | 6 | 2017 | 130 | 0.780 |
Why?
|
| Immunoglobulin E | 6 | 2018 | 215 | 0.760 |
Why?
|
| Inflammation | 14 | 2022 | 1489 | 0.750 |
Why?
|
| NF-kappa B | 5 | 2021 | 440 | 0.750 |
Why?
|
| Guanine | 9 | 2022 | 58 | 0.670 |
Why?
|
| Cytokines | 9 | 2017 | 1339 | 0.660 |
Why?
|
| Pneumonia | 5 | 2018 | 341 | 0.650 |
Why?
|
| Interleukin-8 | 3 | 2017 | 200 | 0.640 |
Why?
|
| Animals | 51 | 2023 | 33912 | 0.630 |
Why?
|
| Interleukin-5 | 6 | 2019 | 49 | 0.590 |
Why?
|
| Lymphocyte Antigen 96 | 2 | 2016 | 3 | 0.590 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2018 | 7 | 0.570 |
Why?
|
| Immunotherapy | 3 | 2018 | 768 | 0.570 |
Why?
|
| Cytosine | 1 | 2018 | 56 | 0.560 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 215 | 0.550 |
Why?
|
| Phenylurea Compounds | 1 | 2018 | 57 | 0.550 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2018 | 14 | 0.540 |
Why?
|
| Antibodies, Monoclonal | 4 | 2019 | 981 | 0.540 |
Why?
|
| Cats | 5 | 2018 | 117 | 0.530 |
Why?
|
| Nitrate Reductase (NAD(P)H) | 2 | 2008 | 2 | 0.530 |
Why?
|
| Blood-Air Barrier | 1 | 2017 | 4 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 275 | 0.510 |
Why?
|
| Mice, Knockout | 13 | 2018 | 3819 | 0.500 |
Why?
|
| Omalizumab | 1 | 2017 | 42 | 0.490 |
Why?
|
| NADPH Oxidases | 3 | 2013 | 109 | 0.480 |
Why?
|
| Adjuvants, Immunologic | 3 | 2003 | 393 | 0.480 |
Why?
|
| Alternaria | 2 | 2015 | 3 | 0.480 |
Why?
|
| Peptide Hydrolases | 1 | 2017 | 131 | 0.470 |
Why?
|
| NADH, NADPH Oxidoreductases | 2 | 2015 | 11 | 0.460 |
Why?
|
| Mice | 35 | 2022 | 18301 | 0.450 |
Why?
|
| Interleukin-18 | 2 | 2015 | 75 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 339 | 0.450 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 351 | 0.450 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 178 | 0.420 |
Why?
|
| Mice, Inbred BALB C | 17 | 2017 | 978 | 0.420 |
Why?
|
| DNA | 7 | 2022 | 1399 | 0.420 |
Why?
|
| Respiratory System | 3 | 2014 | 94 | 0.390 |
Why?
|
| Pandemics | 1 | 2020 | 1118 | 0.380 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2017 | 570 | 0.380 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 757 | 0.370 |
Why?
|
| Th1 Cells | 2 | 2009 | 158 | 0.330 |
Why?
|
| GTP Phosphohydrolases | 2 | 2014 | 155 | 0.310 |
Why?
|
| Interleukin-12 | 3 | 2009 | 125 | 0.300 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2019 | 133 | 0.290 |
Why?
|
| Airway Remodeling | 3 | 2018 | 20 | 0.280 |
Why?
|
| Epithelial Cells | 2 | 2014 | 905 | 0.280 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 1801 | 0.270 |
Why?
|
| Antioxidants | 2 | 2008 | 331 | 0.270 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2009 | 121 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 9 | 2018 | 4738 | 0.260 |
Why?
|
| Interferon-gamma | 1 | 2009 | 544 | 0.260 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 4697 | 0.260 |
Why?
|
| Humans | 40 | 2023 | 131163 | 0.260 |
Why?
|
| Cell Differentiation | 4 | 2012 | 1928 | 0.250 |
Why?
|
| Bronchitis | 1 | 2007 | 29 | 0.250 |
Why?
|
| Interleukin-4 | 3 | 2019 | 144 | 0.220 |
Why?
|
| Nasal Mucosa | 2 | 2017 | 88 | 0.210 |
Why?
|
| Interleukin-13 | 2 | 2019 | 97 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2014 | 183 | 0.200 |
Why?
|
| Cells, Cultured | 10 | 2015 | 2885 | 0.200 |
Why?
|
| Signal Transduction | 11 | 2021 | 4686 | 0.190 |
Why?
|
| Glutathione Disulfide | 2 | 2017 | 19 | 0.190 |
Why?
|
| Biomarkers | 6 | 2018 | 3385 | 0.190 |
Why?
|
| Ovalbumin | 2 | 2014 | 114 | 0.180 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2002 | 7 | 0.180 |
Why?
|
| Drug Therapy | 1 | 2002 | 85 | 0.180 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 38 | 0.180 |
Why?
|
| Mucins | 2 | 2015 | 71 | 0.180 |
Why?
|
| Aldehyde Reductase | 2 | 2013 | 18 | 0.170 |
Why?
|
| Clinical Trials as Topic | 3 | 2020 | 1129 | 0.170 |
Why?
|
| CpG Islands | 1 | 2002 | 337 | 0.170 |
Why?
|
| Cell Line | 6 | 2015 | 2552 | 0.170 |
Why?
|
| Mast Cells | 2 | 2013 | 68 | 0.170 |
Why?
|
| Receptors, Interleukin-4 | 2 | 2019 | 11 | 0.160 |
Why?
|
| Allergists | 1 | 2020 | 9 | 0.160 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 292 | 0.160 |
Why?
|
| Quarantine | 1 | 2020 | 19 | 0.160 |
Why?
|
| Drug Repositioning | 1 | 2020 | 32 | 0.160 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 47 | 0.160 |
Why?
|
| Masks | 1 | 2020 | 34 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 57 | 0.160 |
Why?
|
| Receptors, Virus | 1 | 2020 | 95 | 0.150 |
Why?
|
| Alanine | 1 | 2020 | 160 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 141 | 0.150 |
Why?
|
| Chromatography, Gas | 1 | 2018 | 20 | 0.140 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 2323 | 0.140 |
Why?
|
| Up-Regulation | 3 | 2009 | 825 | 0.140 |
Why?
|
| Pyroglyphidae | 1 | 2018 | 9 | 0.140 |
Why?
|
| Genome | 2 | 2023 | 451 | 0.140 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 93 | 0.130 |
Why?
|
| Insect Bites and Stings | 1 | 2018 | 41 | 0.130 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2017 | 9 | 0.130 |
Why?
|
| Deoxyguanosine | 1 | 2017 | 11 | 0.130 |
Why?
|
| Rhinitis, Allergic | 1 | 2017 | 19 | 0.130 |
Why?
|
| Receptor, PAR-2 | 1 | 2017 | 3 | 0.130 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 127 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 289 | 0.120 |
Why?
|
| Neutrophil Activation | 1 | 2016 | 11 | 0.120 |
Why?
|
| Lactoferrin | 2 | 2007 | 76 | 0.120 |
Why?
|
| Chemokines | 2 | 2009 | 126 | 0.120 |
Why?
|
| Precision Medicine | 2 | 2017 | 388 | 0.120 |
Why?
|
| Inflammation Mediators | 3 | 2014 | 226 | 0.120 |
Why?
|
| Anti-Allergic Agents | 1 | 2016 | 28 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2016 | 125 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2550 | 0.110 |
Why?
|
| Carboxypeptidase H | 1 | 2014 | 1 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2017 | 801 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2020 | 807 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 289 | 0.110 |
Why?
|
| Antigens | 1 | 2014 | 105 | 0.100 |
Why?
|
| Administration, Inhalation | 2 | 2007 | 193 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 555 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 710 | 0.100 |
Why?
|
| Mitochondria | 2 | 2009 | 785 | 0.100 |
Why?
|
| Age Factors | 1 | 2020 | 2825 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2015 | 761 | 0.100 |
Why?
|
| Oxidation-Reduction | 3 | 2015 | 436 | 0.100 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 71 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 176 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2018 | 2406 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 301 | 0.100 |
Why?
|
| Prevalence | 1 | 2020 | 2701 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2014 | 166 | 0.100 |
Why?
|
| Receptors, Chemokine | 2 | 2004 | 47 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 65 | 0.090 |
Why?
|
| Antibody Specificity | 2 | 2004 | 164 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2013 | 106 | 0.090 |
Why?
|
| Cell Movement | 2 | 2021 | 876 | 0.090 |
Why?
|
| Airway Obstruction | 1 | 2014 | 173 | 0.090 |
Why?
|
| Female | 15 | 2017 | 70963 | 0.090 |
Why?
|
| Macrophages, Alveolar | 2 | 2002 | 52 | 0.090 |
Why?
|
| Peroxides | 1 | 2011 | 8 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 88 | 0.090 |
Why?
|
| Oxidants | 1 | 2011 | 24 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3061 | 0.090 |
Why?
|
| Autophagy | 1 | 2015 | 417 | 0.090 |
Why?
|
| Actins | 1 | 2014 | 321 | 0.090 |
Why?
|
| Necrosis | 1 | 2012 | 192 | 0.090 |
Why?
|
| ras Proteins | 1 | 2012 | 140 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 650 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2017 | 889 | 0.080 |
Why?
|
| Down-Regulation | 3 | 2012 | 645 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 300 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1363 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2009 | 10 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 25 | 0.080 |
Why?
|
| Electron Transport Complex III | 1 | 2009 | 4 | 0.080 |
Why?
|
| Enzyme Induction | 1 | 2009 | 92 | 0.080 |
Why?
|
| Histamine Release | 1 | 2009 | 10 | 0.070 |
Why?
|
| Plant Proteins | 2 | 2007 | 86 | 0.070 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2009 | 25 | 0.070 |
Why?
|
| Tretinoin | 1 | 2009 | 95 | 0.070 |
Why?
|
| Time Factors | 2 | 2016 | 6196 | 0.070 |
Why?
|
| Ozone | 2 | 2014 | 18 | 0.070 |
Why?
|
| Interleukins | 1 | 2009 | 122 | 0.070 |
Why?
|
| Serotonin | 1 | 2009 | 208 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2008 | 36 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3359 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2012 | 849 | 0.070 |
Why?
|
| Transcriptome | 1 | 2015 | 1103 | 0.070 |
Why?
|
| Antigen Presentation | 1 | 2008 | 110 | 0.070 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2008 | 32 | 0.070 |
Why?
|
| Immunity, Mucosal | 1 | 2008 | 95 | 0.070 |
Why?
|
| Tocopherols | 1 | 2007 | 6 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2012 | 1571 | 0.060 |
Why?
|
| Ascorbic Acid | 1 | 2007 | 72 | 0.060 |
Why?
|
| Amaranthus | 1 | 2006 | 1 | 0.060 |
Why?
|
| Oxygenases | 1 | 2006 | 4 | 0.060 |
Why?
|
| Chloride Channels | 1 | 2007 | 55 | 0.060 |
Why?
|
| Superoxides | 1 | 2007 | 125 | 0.060 |
Why?
|
| Acetylcysteine | 1 | 2007 | 79 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 633 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 664 | 0.060 |
Why?
|
| Adult | 3 | 2017 | 31282 | 0.060 |
Why?
|
| Male | 3 | 2017 | 64957 | 0.060 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2005 | 18 | 0.060 |
Why?
|
| Aldehydes | 1 | 2005 | 27 | 0.060 |
Why?
|
| Protein Subunits | 2 | 2002 | 157 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 299 | 0.050 |
Why?
|
| Epithelium | 1 | 2005 | 335 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2005 | 585 | 0.050 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2023 | 13 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 386 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 71 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2015 | 576 | 0.050 |
Why?
|
| Cricetinae | 1 | 2023 | 362 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2004 | 227 | 0.050 |
Why?
|
| Bronchi | 3 | 2009 | 98 | 0.050 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2002 | 14 | 0.050 |
Why?
|
| RNA Interference | 2 | 2014 | 491 | 0.050 |
Why?
|
| Obesity | 1 | 2014 | 2426 | 0.050 |
Why?
|
| Forecasting | 1 | 2004 | 351 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 125 | 0.050 |
Why?
|
| Receptors, CCR3 | 1 | 2002 | 6 | 0.050 |
Why?
|
| Chemokine CCL7 | 1 | 2002 | 7 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2002 | 92 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2002 | 52 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2002 | 92 | 0.040 |
Why?
|
| Anaphylaxis | 1 | 2002 | 94 | 0.040 |
Why?
|
| Imidazoles | 1 | 2002 | 219 | 0.040 |
Why?
|
| Pyridines | 1 | 2002 | 255 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2002 | 212 | 0.040 |
Why?
|
| Young Adult | 1 | 2015 | 10103 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 688 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 502 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 573 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 619 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 786 | 0.040 |
Why?
|
| Biological Therapy | 1 | 2019 | 26 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2004 | 993 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 663 | 0.040 |
Why?
|
| Insecta | 1 | 2018 | 45 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 597 | 0.030 |
Why?
|
| Horses | 1 | 2018 | 94 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2009 | 40 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 159 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 558 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 254 | 0.030 |
Why?
|
| Middle Aged | 1 | 2017 | 28601 | 0.030 |
Why?
|
| Phenotype | 2 | 2018 | 4497 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2009 | 765 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 50 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2015 | 26 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2015 | 50 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 83 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 133 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 1722 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 3748 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2015 | 130 | 0.030 |
Why?
|
| Airway Resistance | 1 | 2014 | 31 | 0.030 |
Why?
|
| Stress Fibers | 1 | 2014 | 3 | 0.030 |
Why?
|
| Body Fluids | 1 | 2014 | 45 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 146 | 0.030 |
Why?
|
| Sulfur Dioxide | 1 | 2014 | 7 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 645 | 0.030 |
Why?
|
| Immunity | 1 | 2015 | 178 | 0.030 |
Why?
|
| Volatile Organic Compounds | 1 | 2014 | 13 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2014 | 152 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 192 | 0.030 |
Why?
|
| Telomere | 1 | 2015 | 219 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2015 | 245 | 0.030 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 78 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2015 | 154 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 299 | 0.020 |
Why?
|
| Imidazolidines | 1 | 2013 | 4 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2014 | 324 | 0.020 |
Why?
|
| NADPH Oxidase 4 | 1 | 2013 | 13 | 0.020 |
Why?
|
| Tryptases | 1 | 2013 | 17 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2013 | 27 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 101 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 419 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 335 | 0.020 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2012 | 19 | 0.020 |
Why?
|
| Vaccination | 1 | 2018 | 1060 | 0.020 |
Why?
|
| Guanosine Diphosphate | 1 | 2012 | 12 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 2012 | 38 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1882 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1211 | 0.020 |
Why?
|
| Air Pollutants | 1 | 2014 | 124 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2011 | 30 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 48 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 63 | 0.020 |
Why?
|
| Oxazines | 1 | 2011 | 33 | 0.020 |
Why?
|
| Homeostasis | 1 | 2015 | 712 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 172 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 437 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 686 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2014 | 398 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 200 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 889 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1246 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2009 | 8 | 0.020 |
Why?
|
| Benzophenanthridines | 1 | 2009 | 3 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1371 | 0.020 |
Why?
|
| Chickens | 1 | 2009 | 267 | 0.020 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2009 | 23 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2009 | 18 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 70 | 0.020 |
Why?
|
| Exocytosis | 1 | 2009 | 65 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 113 | 0.020 |
Why?
|
| Iron | 1 | 2011 | 304 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2009 | 272 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2595 | 0.020 |
Why?
|
| Oxygen | 1 | 2011 | 548 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 318 | 0.020 |
Why?
|
| Aging | 1 | 2015 | 1242 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1205 | 0.020 |
Why?
|
| Particle Size | 1 | 2006 | 135 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1618 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1591 | 0.010 |
Why?
|
| NADP | 1 | 2005 | 57 | 0.010 |
Why?
|
| NAD | 1 | 2005 | 52 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 1321 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 928 | 0.010 |
Why?
|
| Proteomics | 1 | 2009 | 615 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 1013 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2004 | 34 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 83 | 0.010 |
Why?
|
| Microtubule Proteins | 1 | 2004 | 28 | 0.010 |
Why?
|
| Chimera | 1 | 2002 | 79 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 780 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2395 | 0.010 |
Why?
|
| Receptors, Interleukin-5 | 1 | 2002 | 5 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 30 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 109 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 36 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3464 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 219 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 588 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2002 | 138 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1319 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2002 | 552 | 0.010 |
Why?
|